CVS Health (CVS) Tops Q3 EPS by 7c; Trims, Narrows FY16 EPS Outlook

November 8, 2016 6:56 AM EST
Get Alerts CVS Hot Sheet
Trade CVS Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

CVS Health (NYSE: CVS) reported Q3 EPS of $1.64, $0.07 better than the analyst estimate of $1.57. Revenue for the quarter came in at $44.6 billion versus the consensus estimate of $45.29 billion.

CVS noted, Adjusted EPS excludes $197 million and $160 million of intangible asset amortization for the three months ended September 30, 2016 and 2015, respectively. Adjusted EPS for the three months ended September 30, 2016 also excludes $65 million of acquisition-related integration costs and the loss on early extinguishment of debt of $101 million.

GUIDANCE:

CVS Health sees FY2017 EPS of $5.77-$5.93, versus the consensus of $6.53.

CVS Health sees FY2016 EPS of $5.77-$5.83, versus prior guidance of $5.81-$5.89 and the consensus of $5.85.

For earnings history and earnings-related data on CVS Health (CVS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance

Related Entities

Earnings, Definitive Agreement

Add Your Comment